Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?

Aaron Scott Mansfield

doi:10.1016/j.lungcan.2017.01.004

Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?

Aaron Scott Mansfield

Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	49-51
Number of pages	3
Journal	Lung Cancer
Volume	105
DOIs	https://doi.org/10.1016/j.lungcan.2017.01.004
State	Published - Mar 1 2017

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

Access to Document

10.1016/j.lungcan.2017.01.004

Cite this

@article{d2123ee8364749d5ab8e80c5a50dc6c1,

title = "Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?",

author = "Mansfield, {Aaron Scott}",

year = "2017",

month = mar,

day = "1",

doi = "10.1016/j.lungcan.2017.01.004",

language = "English (US)",

volume = "105",

pages = "49--51",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Immune checkpoint inhibition in malignant mesothelioma

T2 - Does it have a future?

AU - Mansfield, Aaron Scott

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85009495954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009495954&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2017.01.004

DO - 10.1016/j.lungcan.2017.01.004

M3 - Editorial

C2 - 28089229

AN - SCOPUS:85009495954

SN - 0169-5002

VL - 105

SP - 49

EP - 51

JO - Lung Cancer

JF - Lung Cancer

ER -

Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this